Osteoporosis screening recommendations may miss two-thirds of women aged 50 to 64

January 31, 2014

FINDINGS:

Women who are 65 and older routinely undergo bone-density testing to screen for osteoporosis. But for those between the ages of 50 and 64, it has been unclear who should be screened.

Researchers sought to determine how well the current screening strategy recommended by the U.S. Preventive Services Task Force -- the independent expert panel appointed by the federal government to review and recommend various screenings -- would perform in identifying candidates in this age range for screening.

Using health data on women ages 50-64 from the Women's Health Initiative study, the researchers found that the current strategy would identify only 34 percent of women who actually had bone-mineral density in the osteoporosis range.

IMPACT:

The U.S. Preventive Services Task Force strategy may not identify the majority of women in the 50-64 age group who would be potential candidates for osteoporosis therapy. As a result, following the strategy may lead to missed opportunities to decrease fracture risk in at-risk women.
-end-
AUTHOR:

Lead study author Dr. Carolyn Crandall, a professor of medicine in the division of general internal medicine and health services research at the David Geffen School of Medicine at UCLA, is available for interviews.

FUNDING:

Crandall received support from UCLA's Jonsson Comprehensive Cancer Center. The Women's Health Initiative is funded by the NIH's National Heart, Lung and Blood Institute (contracts HSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C).

JOURNAL:

The research was published this month in the Journal of Bone and Mineral Research

University of California - Los Angeles Health Sciences

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.